Header Logo

Connection

Theodore Pincus to Receptors, Tumor Necrosis Factor

This is a "connection" page, showing publications Theodore Pincus has written about Receptors, Tumor Necrosis Factor.
  1. Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials. J Rheumatol. 2006 Dec; 33(12):2372-5.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.